Anthropic Poised to Reach 109 Billion in Revenue and First Profitable Quarter Source Indicates Compass Therapeutics Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Takes Center Stage CNL Q1 2026 Earnings EPS Falls Short of Estimates as Exploration Costs Weigh MLTX Q1 2026 Earnings WiderthanExpected Loss but Strong Stock Rally ELUT Q1 2026 Earnings EPS Misses Estimates as Stock Moves Higher Samsung Compensation Deal Could Influence Labour Negotiations Across South Korean Industries